Categories: News

Chery Group Becomes the Fastest-climbing Automaker in Fortune Global 500, Powerfully Empowering LEPAS’s Global Growth

WUHU, China, Aug. 7, 2025 /PRNewswire/ — Chery Group, LEPAS’s parent company, has recently achieved remarkable feats. In the 2025 Fortune Global 500 list, it surged 152 places to 233rd, becoming the year’s fastest-rising automaker. A month earlier, its cumulative exports exceeded 5 million units, a first for Chinese automotive brands. This “Double 500” milestone not only showcases Chery’s global competitiveness but also fuels LEPAS’s globalization.

- Advertisement -

As a pioneer in Chery’s globalization strategy, LEPAS embodies a vision for future mobility. It adopts the integration strategy of “Leopard Aesthetic Design, Exquisite Third Space, Intelligent Safety, and Full-scenario Super Platform” to handle diverse travel scenarios, promotes the philosophy “Elegance is Power”, and brings technology and warmth to global users’ “exquisite life”.

- Advertisement -

Chery’s improved Global 500 ranking and export breakthrough serve as “trust endorsements” for LEPAS in global markets. With 22 years as China’s top passenger car exporter and over 17 million global users, Chery provides a user base for LEPAS. LEPAS can leverage Chery’s mature overseas sales and service networks instead of building channels from scratch, accelerating its “Exquisite Life Experience Journey”.

- Advertisement -

Integral to Chery’s strategy, LEPAS is deeply embedded in the group’s global resources across R&D, manufacturing, and supply chain. For instance, sharing Chery’s cutting-edge tech, LEPAS has developed full-link product capabilities to stay industry-leading.

- Advertisement -

Zhong Wei, LEPAS’s Deputy CEO, noted “LEPAS was born in Rome“. Empowered by Chery, LEPAS has advanced rapidly: its first model, L8, rolled off the line in April, favored by urban elites for its design, intelligent cockpit, space, and safety. On July 23, its “L8 + L6 + L4” lineup debuted at the Indonesia International Auto Show, securing initial orders and offering a “new standard for exquisite life travel”.

- Advertisement -

Chery’s “Double 500” achievements, spanning trust, channels, R&D, and industrial chains, act as an “acceleration engine” for LEPAS. Empowered by Chery, LEPAS, with its “Colorful Life, Masterful Drive” proposition, is scripting a new chapter in the global exquisite travel market.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2745917/4.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/chery-group-becomes-the-fastest-climbing-automaker-in-fortune-global-500-powerfully-empowering-lepass-global-growth-302523981.html

- Advertisement -

Recent Posts

Hyundai Motor Group Showcases Hydrogen Technologies Across the Value Chain at World Hydrogen Expo in Korea

Hyundai Motor Group, together with its 7 affiliates, highlights cutting-edge hydrogen technologies and real-world applications…

3 hours ago

Spectacular celebrations as the Olympic flame arrives in Italy ahead of the Olympic Winter Games Milano Cortina 2026

05 December 2025 - Celebrations have taken place in Rome to mark the arrival of the…

3 hours ago

14th Olympic Summit on 11 December 2025 Information for the media

05 December 2025 - The International Olympic Committee (IOC) will host the 14th Olympic Summit on…

3 hours ago

CocaCola music festival set to ignite Olympic Torch Relay celebrations in Rome

05 December 2025 - As the Olympic flame prepares to begin its journey through Italy ahead…

3 hours ago

Godrej Industries Group’s Assistive Tech Conference promotes accessible and equitable workplaces in India

MUMBAI, India, Dec. 6, 2025 /PRNewswire/ -- Godrej Industries Group recently hosted its inaugural Assistive…

4 hours ago

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful improvement with toripalimab…

6 hours ago